Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry (SMART Registry)

NCT03075215 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT03075215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03075215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry (SMART Registry)
Lead sponsor
Boston Scientific Corporation
Phase
Observational
Overall status
Completed
Start date
April 14, 2017
Completion date
November 15, 2021
Enrollment
2,044 (actual)
Sites
139

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure